CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Inovalon›
Library
Inovalon

Inovalon

Inovalon provides cloud-based healthcare analytics software powered by real-world data for payers, providers, pharmacies, and life sciences organizations.

Operating headquarters
Bowie, MD, US🇺🇸
Founded
1998
Loading
Overview
M & A
Compare
Fundraising
Employees
News
Library

Inovalon - Library

inovalon.com·Crawled Oct 9, 2026·

Topics

Publication type

Content origin
Row density

Blog

1 page
  1. Webinars/wcc/eh/4561502/inovalon-webinars

    Explore our library of webinars featuring experts from across the healthcare landscape. Stay on top of the latest trends, learn how to improve perform

Homepage

1 page
  1. Homepage/

    Inovalon is a leading provider of data and solutions empowering data-driven healthcare. Let's transform healthcare together.

Coverage

5 items
  1. 2026 Inovalon Impact Awards Honor Healthcare Innovatorsinovalon.com/news/2026-inovalon-impact-awards-honor-healthcare-innovators/

    Inovalon recognizes four healthcare leaders with its 2026 Impact Awards for measurable gains in patient safety, claims volume, quality outreach, and pharmacy growth.

    Sep 2026 · InovalonNews article

  2. ScriptMed® Achieves Surescripts Certification for RxTransfer to Support Specialty, Infusion, and Hub Pharmaciesinovalon.com/news/scriptmed-achieves-surescripts-certification-for-rxtransfer-to-support-specialty-infusion-and-hub-pharmacies/

    Inovalon's ScriptMed achieves Surescripts RxTransfer certification to support specialty, infusion, and hub pharmacies. The certification replaces fax-and-phone prescription transfers with electronic status tracking.

    Sep 2026 · InovalonNews article

  3. New Inovalon Research Identifies Preventable Drivers of Claim Denials and Prior Authorization Delaysinovalon.com/news/new-inovalon-research-identifies-preventable-drivers-of-claim-denials-and-prior-authorization-delays/

    Inovalon reports findings from a survey of more than 400 revenue cycle leaders, identifying front-end workflows as drivers of most claim denials and finding that 93% still manage prior authorization manually. The research focuses on preventable operational issues in claims and authorization processes.

    Aug 2026 · InovalonNews article

  4. Inovalon and OMNY Health Partner to Launch Linked Real-World Dataset to Accelerate Research and Improve Patient Outcomesinovalon.com/news/inovalon-and-omny-health-partner-to-launch-linked-real-world-dataset-to-accelerate-research-and-improve-patient-outcomes/

    Inovalon and OMNY Health partner to create a linked real-world dataset combining claims and electronic health record (EHR) data. The dataset is intended to help researchers study disease progression and treatment outcomes, with the stated goals of accelerating research and improving patient outcomes.

    Aug 2026 · InovalonNews article